hydroxychloroquine has been researched along with Pulmonary Sarcoidosis in 12 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Diffuse pulmonary sarcoidosis is very rare in non-Scandinavian white Caucasian children, yet in the winter of 1992 two Caucasian males, aged 11." | 5.30 | Hydroxychloroquine therapy of diffuse pulmonary sarcoidosis in two Australian male children. ( Cooper, DM; Henry, RL; Hilton, JM, 1997) |
| "Sarcoidosis is a systemic condition characterized by formation of granulomas that can involve many organ systems, with the lungs and intrathoracic lymph nodes involved in more than 90% of cases." | 1.62 | Less Common Respiratory Conditions: Sarcoidosis. ( Falk, N; Garland, S; Wilk, A, 2021) |
| "Lupus pernio (LP) occurs in the form of smooth, bright nodules and plaques on the nose, ear, lips, and cheeks." | 1.56 | A case of chronic sarcoidosis presenting with lupus pernio. ( Duru Çetinkaya, P, 2020) |
| "Diffuse pulmonary sarcoidosis is very rare in non-Scandinavian white Caucasian children, yet in the winter of 1992 two Caucasian males, aged 11." | 1.30 | Hydroxychloroquine therapy of diffuse pulmonary sarcoidosis in two Australian male children. ( Cooper, DM; Henry, RL; Hilton, JM, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 4 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jamilloux, Y | 1 |
| El Jammal, T | 1 |
| Bert, A | 1 |
| Sève, P | 1 |
| Duru Çetinkaya, P | 1 |
| Bénézit, F | 1 |
| Le Bot, A | 1 |
| Jouneau, S | 1 |
| Lemaître, F | 1 |
| Pronier, C | 1 |
| Lentz, PA | 1 |
| Patrat-Delon, S | 1 |
| Revest, M | 1 |
| Thibault, V | 1 |
| Tattevin, P | 1 |
| Garland, S | 1 |
| Falk, N | 1 |
| Wilk, A | 1 |
| Marchetti, M | 1 |
| Baker, MG | 1 |
| Noland, MM | 1 |
| Carragoso, A | 1 |
| Silva, JR | 1 |
| Capelo, J | 1 |
| Faria, B | 1 |
| Gaspar, O | 1 |
| Ginarte, M | 1 |
| Zulaica, A | 1 |
| Toribio, J | 1 |
| Gol'dshteĭn, VD | 1 |
| Ivantsova, LN | 1 |
| Hilton, JM | 1 |
| Cooper, DM | 1 |
| Henry, RL | 1 |
| Lavergne, F | 1 |
| Clerici, C | 1 |
| Sadoun, D | 1 |
| Brauner, M | 1 |
| Battesti, JP | 1 |
| Valeyre, D | 1 |
| Ozerova, LV | 1 |
| Romanov, VV | 1 |
| Zaĭtseva, IP | 1 |
| Rybakova, NP | 1 |
| Shemetun, ON | 1 |
| Carriere, M | 1 |
| Loche, F | 1 |
| Schwarze, HP | 1 |
| Bouissou, X | 1 |
| Laplanche, G | 1 |
| Bazex, J | 1 |
1 review available for hydroxychloroquine and Pulmonary Sarcoidosis
| Article | Year |
|---|---|
[Hydroxychloroquine for non-severe extra-pulmonary sarcoidosis].
Topics: Adrenal Cortex Hormones; Humans; Hydroxychloroquine; Sarcoidosis; Sarcoidosis, Pulmonary; Steroids | 2022 |
11 other studies available for hydroxychloroquine and Pulmonary Sarcoidosis
| Article | Year |
|---|---|
A case of chronic sarcoidosis presenting with lupus pernio.
Topics: Antirheumatic Agents; Biopsy; Chilblains; Diagnosis, Differential; Female; Humans; Hydroxychloroquin | 2020 |
COVID-19 in Patient with Sarcoidosis Receiving Long-Term Hydroxychloroquine Treatment, France, 2020.
Topics: Adult; Antimalarials; Coronavirus Infections; COVID-19; France; Humans; Hydroxychloroquine; Male; Pa | 2020 |
Less Common Respiratory Conditions: Sarcoidosis.
Topics: Biopsy; Humans; Hydroxychloroquine; Lung; Sarcoidosis; Sarcoidosis, Pulmonary | 2021 |
Treatment of subcutaneous sarcoidosis with hydroxychloroquine: report of 2 cases.
Topics: Adrenal Cortex Hormones; Biopsy; Contraindications; Diabetes Mellitus, Type 1; Diabetes Mellitus, Ty | 2014 |
A patient with sarcoidosis and antiphospholipid syndrome.
Topics: Anticoagulants; Antiphospholipid Syndrome; Antirheumatic Agents; Drug Therapy, Combination; Female; | 2008 |
Morpheaform sarcoidosis.
Topics: Aged; Dermatologic Agents; Diagnosis, Differential; Drug Therapy, Combination; Humans; Hydroxychloro | 2006 |
[Long-term results of treatment and prediction in patients with sarcoidosis].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Chloroquine; Female; Follow-Up Studies; Humans; Hydr | 2006 |
Hydroxychloroquine therapy of diffuse pulmonary sarcoidosis in two Australian male children.
Topics: Antimalarials; Australia; Biopsy, Needle; Child; Follow-Up Studies; Forced Expiratory Volume; Humans | 1997 |
Airway obstruction in bronchial sarcoidosis: outcome with treatment.
Topics: Administration, Oral; Adult; Airway Obstruction; Antirheumatic Agents; Biopsy; Bronchial Diseases; B | 1999 |
[Comparative evaluation of the effectiveness of traditional and combined therapies of patients with sarcoidosis].
Topics: Adrenal Cortex Hormones; Antioxidants; Antirheumatic Agents; Evaluation Studies as Topic; Follow-Up | 1999 |
Sarcoid panniculitis.
Topics: Humans; Hydroxychloroquine; Male; Middle Aged; Panniculitis; Sarcoidosis; Sarcoidosis, Pulmonary | 2000 |